Does UnitedHealth Deserve More Credit for Q4?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Does UnitedHealth Deserve More Credit for Q4?

© CherriesJD / Getty Images

When UnitedHealth Group Inc. (NYSE: UNH | UNH Price Prediction) reported its fourth-quarter financial results before the markets opened on Wednesday, the Minnesota-based health care giant said that it had $3.90 in earnings per share (EPS) and $60.9 billion in revenue. That compared with consensus estimates of $3.78 in EPS and $61.04 billion in revenue, as well as the $3.28 per share and $58.42 billion posted in the same period of last year.

During the latest quarter, total revenues grew $2.5 billion or 4.1%, year over year, reflecting balanced, broad-based revenue growth across the businesses.

UnitedHealthcare revenues increased 4.2% year over year to $48.2 billion. Third-quarter 2019 earnings from operations at UnitedHealthcare grew by 16.7%, driven by revenue growth and strong cost disciplines.

Optum revenues grew by 8.0% year over year to $29.8 billion, and earnings from operations advanced 11.1%.

Looking ahead to the 2020 full year, the company now expects to see EPS in the range of $16.25 to $16.55. Consensus estimates call for $16.46 in EPS and $260.95 billion in revenue for the year.

[nativounit]

David S. Wichmann, CEO of UnitedHealth, commented:

The dedicated women and men of UnitedHealth Group work together each day to improve outcomes and the patient and physician experience, while making health care more affordable, enabling us to serve more people better, while positioning us for continued growth in 2020.

Shares of UnitedHealth were last seen relatively flat on Wednesday morning, at $288.10 in a 52-week range of $208.07 to $300.00. The consensus price target is $325.68.

[recirclink id=636108]
[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618